Tian Kai Wan Wu, Yi Zhi Qian Li — Call for Nominations: 2023 VB-link Award for Future Healthcare Technology Transfer
Promoting the transfer and commercialization of scientific and technological achievements is a crucial task in China’s implementation of the innovation-driven development strategy. It serves as a key link in strengthening the close integration of science and technology with the economy, and holds significant importance for advancing structural reforms—particularly supply-side structural reforms—supporting economic transformation and upgrading as well as industrial restructuring, fostering mass entrepreneurship and innovation, and creating new engines for economic growth.
Since the beginning of the 21st century, global scientific and technological innovation has entered an unprecedentedly intensive and dynamic period. A new round of scientific and technological revolution and industrial transformation is reshaping the global innovation landscape and restructuring the global economic structure. Today, we are witnessing a historic convergence between this new global wave of scientific and technological revolution and industrial transformation and China’s transition in its development model. The state has vigorously advanced reforms of the science and technology system, achieving comprehensive efforts, breakthroughs in multiple areas, and in-depth development. The main architectural framework of these reforms has been established, and substantive breakthroughs have been made in key fields and critical links. With the implementation of the national innovation-driven development strategy and the rollout of related policies, medical innovation has garnered significant attention. However, the conversion rate of medical scientific and technological achievements in China remains low. The average annual conversion rate for major scientific and technological achievements in China is only 20%, with the conversion rate for medical scientific and technological achievements falling below 8%. In contrast, this rate approaches 70% in the United States and Japan. Therefore, the translation of medical scientific and technological achievements in China holds immense potential for development and considerable room for growth.
VB100, VCBeat, and Eggshell Research Institute Launch VB-link Award, China’s First Award System Focusing on Key Forces in Achievement Transformation, aiming to select translational innovators who truly represent the future of healthcare, identify the core forces driving China’s future healthcare industry, promote innovative transformation in the health and medical sector, and enhance the conversion rate of medical scientific and technological achievements in China.
Three Categories of Awards, Showcasing the Era’s Achievements
1. Annual Outstanding Fund for Translational Innovation
Selection Criteria:A technology transfer fund that provides financial support, entrepreneurial training, project incubation, and industry empowerment for the commercialization of medical and health science and technology achievements.
Evaluation Dimensions:Manage the fund size for investments in the commercialization of medical and health technology achievements, annual progress in investment incubation and post-investment value addition, and the diversity of annual activities promoting the translation of medical research outcomes.
2. Annual Outstanding Center for Medical Translation and Innovation
Candidates for Selection:ChinaHigher Education Institutions/The Translational Center of the Hospital Institution.
Evaluation Dimensions:Annual scale of medical technology achievement transformation, diversity of annual medical research achievement transformation activities, service capacity for medical technology achievement transformation, and outstanding achievements in medical technology achievement transformation.
3. Third-Party Agencies for Annual Innovation Commercialization
Eligible Candidates:Third-party service agencies, including achievement promotion institutions for the commercialization of medical scientific and technological achievements, university science parks, technology transaction centers, technology development companies, productivity promotion centers, intellectual property agencies, entrepreneurship parks, and incubators.
Evaluation Dimensions:Annual scale of medical technology transfer services, annual diversity of medical research achievement transfer services, and capacity for medical technology transfer services.
4. Outstanding Enterprise in Annual Transformation Innovation
Selection Criteria:Listed companies/unicorns that actively promote the commercialization of scientific research achievements.
Evaluation Dimensions:Corporate Annual Performance in the Growth of Medical Technology Transfer Value, Innovation Breakthroughs, and Social Responsibility
Project Category
1. Annual Innovation Commercialization Project – [Biopharmaceutical Group]
Selection Criteria:Representatives of biomedical research projects with potential for translation or existing case studies.
Evaluation Dimensions:Comprehensively evaluate the performance of candidate biomedical projects across five dimensions: innovation level of translational outcomes, technological advancement, technological maturity, application effectiveness and impact, and economic benefits.
2. Annual Innovation Commercialization Project – [Medical Device Group]
Candidates for Selection:Representative projects of medical device research achievements with potential for commercialization or existing case studies.
Evaluation Dimensions:Comprehensively evaluate the performance of candidate medical device projects across five dimensions: innovation level of translational outcomes, technological advancement, technology maturity, application effectiveness and impact, and economic benefits.
Characters
1. Outstanding Young Scientist Award for Annual TranslationScientist
Candidates:Young scientists engaged in the research and development of medical technology innovations, exploration in the field of life sciences, and the industrialization of medical technologies.
Evaluation Dimensions:Personal Influence, Innovative Influence, Industry Influence.
2. Outstanding Hospital Director of the Year in Transformation and Innovation
Candidates for Selection:Hospital presidents who lead the frontier of medical innovation and significantly promote the translation of scientific research achievements in hospitals.
Evaluation Dimensions:Personal Influence, Innovative Influence, Leadership Drive.
3. Outstanding Figure of the Annual Hospital Translation Center
Selection Criteria:Selection of Representative Hospital Technology Transfer Centers That Have Significantly Promoted the Translation of Medical Research Achievements, Targeting Departments Responsible for Research Commercialization in Hospitals.
Evaluation Dimensions:Personal Influence, Innovative Influence, and Leadership Drive.
4. Outstanding Department Director in Annual Translational Innovation
SelectionSubject:IntroductionLead MedicineDepartment directors who pioneer cutting-edge development directions and significantly promote the translation of hospital research achievements.
Evaluation Dimensions:Personal Influence, Innovative Influence, Leadership Drive.
5. Outstanding Figures of the Annual University Technology Transfer Center
Eligible Candidates:Select representative technology transfer centers that have significantly promoted the commercialization of university research achievements, targeting departments responsible for such initiatives at higher education institutions.
Evaluation Dimensions:Personal Influence, Innovative Influence, Leadership Drive.
6. Annual University Technology Transfer Innovation Figure
Eligible Candidates:Targeting academic research experts, this initiative recognizes key figures who have made significant innovative contributions or played a pivotal role in advancing the translation of scientific research achievements.
Evaluation Dimensions:Personal Influence, Innovative Influence, Leadership Drive.
7. Outstanding Technology Transfer Manager of the Year
Eligible Candidates:Technical Manager for the Commercialization of Medical Scientific and Technological Achievements
Evaluation Dimensions:Personal Influence, Innovation Influence, Industry Influence.
8. Outstanding Investor of the Year in Deal Conversion
Eligible Candidates:Early-stage investors focused on the commercialization of medical and healthcare technological innovations.
Evaluation Dimensions:Personal Influence, Innovation Influence, Industry Influence, Leadership Drive.
Selection Method
ApprovedSelf-Registration、Institutional Recommendationscall for nominations, in addition to self-submitted application materials, the Organizing Committee will also select outstanding healthcare enterprises and institutions from the 2023 Future Healthcare Top 100 main list and Pengcheng Award applications as supplements to be included in this evaluation.
FromBreakthroughs in R&D of Medical Scientific and Technological Achievements, Efficiency in the Translation of Medical Scientific and Technological Achievements, and Comprehensiveness in Empowerment by Medical Scientific and Technological Achievementsaspects, etc.Multidimensional, Differentiatedevaluation, ultimately byVB-link Award Jury: Initial Review – Re-evaluation – Announcementselection process.
Selection Process:
1. Award Submission:April 1–June 18
2. Award Evaluation:June 19–June 24
3. Notification of Results:June 25–June 27
4. Award Announcement:June 28–29 · VB-link Conference
Application Method
Please scan the QR code or click to copy the link to fill out the registration form online.
1. Institutions
https://vb100.mike-x.com/r80Re
2. Project Category
https://vb100.mike-x.com/I4znr
3. People
https://vb100.mike-x.com/JuQ5G
Note: 1. To prevent omissions in submission materials, facilitate data analysis, and enable dynamic notifications to enterprises, online submission is the only accepted method for this cycle; Word application forms will not be accepted. Thank you for your understanding!
2. The submission page does not support saving; please ensure that your information is successfully submitted!
Application Consultation:
VB100 - Ms. Peng: 13364027163 (WeChat ID same as phone number)
Please add us on WeChat with the note [Name-Company-VBlink Award Application]
1、Community-Wide Resource Recommendations· Publication of award-winning articles to increase the visibility of applicants, with recommendations featured on the VCBeat website and across the VB100 media matrix; follow-up matchmaking services are provided to connect winners with industry players, investors, and industrial parks.
2、Close-Up Interaction at the Award Ceremony· Award-winning organizations and individuals will be invited to attend the award ceremony, where they will share the stage with representatives of numerous outstanding organizations and engage in face-to-face exchanges with industry peers to spark collaborative opportunities.
3、Direct Access2023 Future Healthcare Achievement Transformation and Cooperation Conference· By submitting application materials, participating organizations will receive three tickets to the "2023 Future Medical Achievement Transformation and Cooperation Conference," enabling more in-depth exchanges with government officials, industry peers, potential partners, and other professionals.
4、Opportunity to Present at the Conference· Outstanding award recipients may be invited to deliver speeches and participate in roundtable discussions at the forum, sharing cutting-edge translational achievements and insights with professional attendees based on their respective business specialties.
On the 2023 Future Healthcare Achievement Transformation and Cooperation Conference
Future Medical Achievement Transformation and Cooperation Conference (hereinafter referred to as the VB-Link Conference) is China’s first industry summit oriented by market demand, focusing on the sharing of cutting-edge information, exhibition, matchmaking, and cooperation in the transformation of medical scientific and technological achievements. It aims to gather core forces across the value chain of medical achievement transformation, creating a comprehensive exchange and matchmaking platform for the entire industry through diverse formats such as calls for achievement needs, hospital-enterprise need matching, specialty innovation competitions, frontier thematic summits, and early-stage project roadshows.
Seizing the opportunity presented by the release of the “Top 10 Predictions for Future Healthcare Innovation” and the Link Awards, the conference brings together leading domestic and international stakeholders across the translation continuum—including top universities, medical institutions, research institutes, listed industry leaders, investment firms, incubators, engineering centers, and intellectual property and legal service providers—to foster effective interaction and collaboration among industry, academia, research, and commercialization sectors, thereby accelerating the development of a new ecosystem for achievement transformation.
-END-